Literature DB >> 3147094

Treating HIV positive haemophiliacs with zidovudine.

.   

Abstract

Entities:  

Keywords:  Biomedical and Behavioral Research; Health Care and Public Health

Mesh：

Substances：

Year:  1988        PMID： 3147094      PMCID： PMC1835277          DOI： 10.1136/bmj.297.6663.1608-b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Randomised, double-blind, placebo-controlled trial of ditiocarb sodium ('Imuthiol') in human immunodeficiency virus infection.

Authors:  J M Lang; J L Touraine; C Trepo; P Choutet; M Kirstetter; A Falkenrodt; L Herviou; J M Livrozet; G Retornaz; F Touraine
Journal:  Lancet       Date:  1988-09-24       Impact factor: 79.321

2.  Prevalence of antibodies to human immunodeficiency virus, gonorrhoea rates, and changed sexual behaviour in homosexual men in London.

Authors:  C A Carne; I V Weller; A M Johnson; C Loveday; F Pearce; A Hawkins; A Smith; P Williams; R S Tedder; M W Adler
Journal:  Lancet       Date:  1987-03-21       Impact factor: 79.321

3.  The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.

Authors:  D D Richman; M A Fischl; M H Grieco; M S Gottlieb; P A Volberding; O L Laskin; J M Leedom; J E Groopman; D Mildvan; M S Hirsch
Journal:  N Engl J Med       Date:  1987-07-23       Impact factor: 91.245

4.  The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.

Authors:  M A Fischl; D D Richman; M H Grieco; M S Gottlieb; P A Volberding; O L Laskin; J M Leedom; J E Groopman; D Mildvan; R T Schooley
Journal:  N Engl J Med       Date:  1987-07-23       Impact factor: 91.245

5.  Effect of zidovudine on serum human immunodeficiency virus antigen levels in symptom-free subjects.

Authors:  F de Wolf; J M Lange; J Goudsmit; P Cload; J de Gans; P T Schellekens; R A Coutinho; A P Fiddian; J van der Noordaa
Journal:  Lancet       Date:  1988-02-20       Impact factor: 79.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.